Cleared Traditional

K933961 - MARSAM MODEL 2000 NEBULIZER

K933961 is an FDA 510(k) clearance for MARSAM MODEL 2000 NEBULIZER, manufactured by Marsam Pharmaceuticals, Inc.. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 767-day FDA review.

K933961 · Marsam Pharmaceuticals, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1995
Decision
767d
Days
Class 2
Risk

K933961 is an FDA 510(k) clearance for the MARSAM MODEL 2000 NEBULIZER. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Marsam Pharmaceuticals, Inc. (Cherry Hill, US). The FDA issued a Cleared decision on September 19, 1995 after a review of 767 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all Marsam Pharmaceuticals, Inc. devices

FDA 510(k) Submission Details - K933961

510(k) Number K933961 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 13, 1993
Decision Date September 19, 1995
Days to Decision 767 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
627d slower than avg
Panel avg: 140d · This submission: 767d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 404
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K933961.
DUAL SPRAY MINISPACER
K955805 · Thayer Medical Corp. · Mar 1996
PULMOMIST
K952326 · Global Medical Ent., Inc. · Feb 1996
JET NEBULIZER
K952249 · Devilbiss Health Care, Inc. · Jan 1996
DEVILBISS MODEL 5500
K946095 · Devilbiss Health Care, Inc. · Aug 1995
3000 AEROSOL TWO
K943990 · Medical Industries America, Inc. · Mar 1995
AIRSEP NEWLIFE AIR OUTLET OPTION
K944020 · Airsep Corp. · Mar 1995